Upgrades
- Guggenheim upgraded the previous rating for Salesforce Inc (NYSE:CRM) from Sell to Neutral. For the second quarter, Salesforce had an EPS of $1.19, compared to year-ago quarter EPS of $1.48. The stock has a 52-week-high of $256.87 and a 52-week-low of $150.87. At the end of the last trading period, Salesforce closed at $153.53.
- For Okta Inc (NASDAQ:OKTA), Guggenheim upgraded the previous rating of Sell to Neutral. In the second quarter, Okta showed an EPS of $0.10, compared to $0.11 from the year-ago quarter. At the moment, the stock has a 52-week-high of $226.49 and a 52-week-low of $58.12. Okta closed at $60.60 at the end of the last trading period.
- For Advent Technologies Holdings Inc (NASDAQ:ADN), Credit Suisse upgraded the previous rating of Underperform to Neutral. In the second quarter, Advent Technologies Hldgs showed an EPS of $0.21, compared to $0.07 from the year-ago quarter. The current stock performance of Advent Technologies Hldgs shows a 52-week-high of $7.08 and a 52-week-low of $1.13. Moreover, at the end of the last trading period, the closing price was at $3.10.
See all analyst ratings upgrades.
Downgrades
- Needham downgraded the previous rating for C3.ai Inc (NYSE:AI) from Buy to Hold. In the first quarter, C3.ai showed an EPS of $0.12, compared to $0.22 from the year-ago quarter. The stock has a 52-week-high of $32.36 and a 52-week-low of $13.37. At the end of the last trading period, C3.ai closed at $14.52.
- Seaport Global downgraded the previous rating for Tilly's Inc (NYSE:TLYS) from Buy to Neutral. In the second quarter, Tilly's showed an EPS of $0.13, compared to $0.66 from the year-ago quarter. The current stock performance of Tilly's shows a 52-week-high of $16.95 and a 52-week-low of $6.87. Moreover, at the end of the last trading period, the closing price was at $7.33.
- According to Credit Suisse, the prior rating for Forma Therapeutics Holdings Inc (NASDAQ:FMTX) was changed from Outperform to Neutral. Forma Therapeutics Hldgs earned $1.10 in the second quarter, compared to $0.92 in the year-ago quarter. The current stock performance of Forma Therapeutics Hldgs shows a 52-week-high of $20.28 and a 52-week-low of $4.95. Moreover, at the end of the last trading period, the closing price was at $20.24.
- According to RBC Capital, the prior rating for Azure Power Global Ltd (NYSE:AZRE) was changed from Outperform to Sector Perform. For the third quarter, Azure Power Global had an EPS of $0.13, compared to year-ago quarter EPS of $0.31. The current stock performance of Azure Power Global shows a 52-week-high of $21.53 and a 52-week-low of $3.26. Moreover, at the end of the last trading period, the closing price was at $3.68.
- HC Wainwright & Co. downgraded the previous rating for Forma Therapeutics Holdings Inc (NASDAQ:FMTX) from Buy to Neutral. Forma Therapeutics Hldgs earned $1.10 in the second quarter, compared to $0.92 in the year-ago quarter. The stock has a 52-week-high of $20.28 and a 52-week-low of $4.95. At the end of the last trading period, Forma Therapeutics Hldgs closed at $20.24.
- According to JP Morgan, the prior rating for LyondellBasell Industries NV (NYSE:LYB) was changed from Overweight to Neutral. LyondellBasell Industries earned $5.19 in the second quarter, compared to $6.13 in the year-ago quarter. At the moment, the stock has a 52-week-high of $117.22 and a 52-week-low of $80.74. LyondellBasell Industries closed at $81.86 at the end of the last trading period.
- For Dow Inc (NYSE:DOW), JP Morgan downgraded the previous rating of Overweight to Neutral. For the second quarter, Dow had an EPS of $2.31, compared to year-ago quarter EPS of $2.72. At the moment, the stock has a 52-week-high of $71.86 and a 52-week-low of $48.27. Dow closed at $49.96 at the end of the last trading period.
See all analyst ratings downgrades.
Initiations
- With a Neutral rating, Atlantic Equities initiated coverage on Palo Alto Networks Inc (NASDAQ:PANW). The price target seems to have been set at $495.00 for Palo Alto Networks. In the fourth quarter, Palo Alto Networks showed an EPS of $2.39, compared to $1.60 from the year-ago quarter. The stock has a 52-week-high of $640.90 and a 52-week-low of $421.55. At the end of the last trading period, Palo Alto Networks closed at $545.15.
- For ProKidney Corp (NASDAQ:PROK), Evercore ISI Group initiated coverage, by setting the current rating at Outperform. In the second quarter, ProKidney showed an EPS of $0.12, compared to $0.09 from the year-ago quarter. The stock has a 52-week-high of $11.98 and a 52-week-low of $6.19. At the end of the last trading period, ProKidney closed at $9.67.
- Stifel initiated coverage on Greif Inc (NYSE:GEF) with a Buy rating. The price target for Greif is set to $90.00. In the third quarter, Greif showed an EPS of $2.35, compared to $1.93 from the year-ago quarter. At the moment, the stock has a 52-week-high of $72.80 and a 52-week-low of $53.65. Greif closed at $65.50 at the end of the last trading period.
- With an Overweight rating, Wells Fargo initiated coverage on PROCEPT BioRobotics Corp (NASDAQ:PRCT). The price target seems to have been set at $49.00 for PROCEPT BioRobotics. At the moment, the stock has a 52-week-high of $46.62 and a 52-week-low of $15.38. PROCEPT BioRobotics closed at $40.38 at the end of the last trading period.
- With a Neutral rating, Atlantic Equities initiated coverage on CrowdStrike Holdings Inc (NASDAQ:CRWD). The price target seems to have been set at $200.00 for CrowdStrike Holdings. In the second quarter, CrowdStrike Holdings showed an EPS of $0.36, compared to $0.11 from the year-ago quarter. The stock has a 52-week-high of $242.00 and a 52-week-low of $130.00. At the end of the last trading period, CrowdStrike Holdings closed at $172.97.
- Atlantic Equities initiated coverage on Fortinet Inc (NASDAQ:FTNT) with an Overweight rating. The price target for Fortinet is set to $76.00. In the second quarter, Fortinet showed an EPS of $0.24, compared to $0.19 from the year-ago quarter. The stock has a 52-week-high of $362.12 and a 52-week-low of $47.37. At the end of the last trading period, Fortinet closed at $48.55.
- With a Buy rating, Stifel initiated coverage on Relay Therapeutics Inc (NASDAQ:RLAY). The price target seems to have been set at $40.00 for Relay Therapeutics. For the second quarter, Relay Therapeutics had an EPS of $0.71, compared to year-ago quarter EPS of $0.64. The current stock performance of Relay Therapeutics shows a 52-week-high of $35.36 and a 52-week-low of $12.65. Moreover, at the end of the last trading period, the closing price was at $24.90.
